Author:
Wei Xiaoting,Zou Zhengyun,Zhang Weizhen,Fang Meiyu,Zhang Xiaoshi,Luo Zhiguo,Chen Jing,Huang Gang,Zhang Peng,Cheng Ying,Liu Jiwei,Liu Jiyan,Zhang Junping,Wu Di,Chen Yu,Ma Xiaobiao,Pan Hongming,Jiang Renbing,Liu Xinlan,Ren Xiubao,Tian Hongqi,Jia Zhongwei,Guo Jun,Si Lu
Reference36 articles.
1. Treatment of metastatic melanoma with a combination of immunotherapies and molecularly targeted therapies;Rager;Cancers,2022
2. Epidemiology of melanoma;Saginala;Med Sci,2021
3. Global burden of cutaneous melanoma in 2020 and projections to 2040;Arnold;JAMA Dermatol,2022
4. Intra-patient heterogeneity of BRAF and NRAS molecular alterations in primary melanoma and metastases;Pellegrini;Acta Derm Venereol,2020
5. Dean L. Vemurafenib therapy and BRAF and NRAS genotype. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries. Bethesda, MD: National Center for Biotechnology Information (US); 2012).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献